RR

Rajesh Ranjan Rashmirathy

Active Director Director DIN 09241043
DIN 09241043 First appointment Jul 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajesh Ranjan Rashmirathy

Data last updated:

Rajesh Ranjan Rashmirathy is a Director at Mandible Pharmaceuticals Private Limited (since 2021). The company operates in Chemicals.

DIN 09241043
Primary Designation Director
Industry Chemicals
First Appointment 15 Jul 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Jul 20212021Active

Board colleagues of Rajesh Ranjan Rashmirathy

NameDINCompanyDesignation
Amit Kumar09241045Mandible Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Mandible Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rajesh Ranjan Rashmirathy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Ranjan Rashmirathy

Rajesh Ranjan Rashmirathy currently holds 1 directorship: Mandible Pharmaceuticals Private Limited (Director, since 15 Jul 2021).

Rajesh Ranjan Rashmirathy was first appointed on 15 Jul 2021 as Director at Mandible Pharmaceuticals Private Limited.

The current boards of Rajesh Ranjan Rashmirathy's companies include Amit Kumar (Mandible Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available